The New Zealand Antimicrobial Resistance Action Plan will be implemented over 5 years, starting in 2017. Some activities will be ongoing, while some will be prioritised in year 1 or in later years.
The Ministry for Primary Industries and Ministry of Health will jointly govern the New Zealand Antimicrobial Resistance Action Plan. Implementing the activities will involve a variety of partners from across the human health, animal health and agriculture sectors.
The plan includes 18 priority action areas with specific activities to be implemented over 5 years. Ongoing and year 1 activities are listed below. Activities may be amended in later years to ensure the success of the plan.
Priority action areas
- Strengthen consumer awareness to improve understanding of antimicrobial resistance and the importance of using antibiotics appropriately.
- Strengthen communication and education initiatives on antimicrobial resistance and stewardship for all prescribers, and those working in the human health, animal health and agricultural sectors.
- Establish a coordinated national surveillance programme of antimicrobial resistance and antimicrobial use in humans, animals and agriculture.
- Develop lists of priority organisms, key resistance genes and antimicrobials for national reporting.
- Implement a national minimum standard for laboratory testing and reporting of antimicrobial susceptibility.
- Support national priorities for research on antimicrobial resistance, antimicrobial consumption and stewardship in human health, animal health and agriculture.
- Develop and update national guidelines and standards for IPC to achieve a nationally consistent approach, and enhance accreditation and quality assurance programmes so that more practitioners follow best-practice IPC measures across human health, animal health and agriculture.
- Promote a cohesive and sustainable ‘one team’ approach to IPC functions in all human health care facilities.
- Encourage continued immunisation to prevent infections.
- Promote prevention and control of zoonotic infections.
- Encourage alternative approaches to reduce infection and the need for antimicrobial use in animals.
- Develop a national programme or standard for AMS in all sectors of human health, including resources and/or targets for use in all sectors.
- Develop a national programme or standard for AMS in animal health.
- Establish a programme of regularly monitoring the controls on antimicrobial veterinary medicines.
- Review the controls (conditions of registration), labelling and advertising of antimicrobial-based trade name products to ensure they are fit for purpose.
- Establish a sustainable national governance structure to coordinate all efforts to minimise antimicrobial resistance.
- Ensure that there is sustainable investment in initiatives to minimise the impacts of antimicrobial resistance. This includes ongoing investment in surveillance, communication, stewardship and infection prevention and control.
- Establish the necessary national and international links and collaborations to implement the AMR Action Plan effectively.